ALLISON CLEMMER: Open Payments
NPI 1366220832 · ROANOKE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,075 in 43 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $916 · 2025 $1,075
Food & beverage: $946Education: $129
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 13 | $368 |
| GENZYME CORPORATION | 11 | $222 |
| GlaxoSmithKline, LLC. | 6 | $137 |
| Optinose US, Inc. | 4 | $92 |
| SANOFI-AVENTIS U.S. LLC | 1 | $70 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $49 |
| Inspire Medical Systems, Inc. | 1 | $44 |
| AstraZeneca Pharmaceuticals LP | 2 | $36 |
| Amgen Inc. | 1 | $28 |
| Stryker Corporation | 1 | $15 |
Products named: DUPIXENT, NUCALA, Xhance, TEZSPIRE, JOURNAVX, INSPIRE, XPRESS LOPROFILE.
Industry payments across VA — which companies pay providers there.
